SCHEMBL9319224

SCHEMBL9319224

COC(=O)c1cc(C(=O)O)ncc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 11/20 0.53
▸ ASPH Q12797 10/20 0.53
▸ KDM8 Q8N371 9/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ RIOX2 Q8IUF8 7/20 0.48
▸ DDT P30046 1/20 0.42
▸ AXL P30530 1/20 0.41
▸ EGLN1 Q9GZT9 1/20 0.40
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRA2 P47869 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ GABRA4 P48169 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10467645 0.83 MAPK1 (0.52) KDM4EMAPK1L3MBTL1GABRPGABRD
SCHEMBL31318735 0.83 KDM4E (0.50) KDM4EASPHKDM8MAPK1L3MBTL1
SCHEMBL1171098 0.82 KDM4E (0.67) KDM4EASPHKDM8RIOX2DDT
SCHEMBL28985760 0.81 NNMT (0.50) KDM4EMAPK1L3MBTL1GABRPGABRD
SCHEMBL30703822 0.78 ASPH (0.45) KDM4EASPHKDM8MAPK1L3MBTL1
SCHEMBL9318874 0.76 KDM4E (0.55) KDM4EASPHKDM8MAPK1L3MBTL1
SCHEMBL9568767 0.76 KDM4E (0.50) KDM4EASPHKDM8MAPK1L3MBTL1
SCHEMBL829544 0.76 CA12 (0.47) KDM4EL3MBTL1
SCHEMBL337450 0.76 CA12 (0.47) KDM4EL3MBTL1
SCHEMBL10616295 0.76 CA12 (0.47) KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0281943-B1 Substituted pyridine-2,4-carboxylic acid derivatives, process for their preparation, their use as well as medicaments based on these compounds HOECHST AG (DE) 1994-01-12 — — EP claimed
Send feedback